CCB
GSK icon

Cutter & Co Brokerage’s GSK GSK Stock Holding History

Cutter & Co Brokerage’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-17,567
Closed -$890K – 256
2016
Q1 		$890K Sell
17,567
-19,971
-53% -$995K 0.41% 67
2015
Q4 		$1.89M Sell
37,538
-2,176
-5% -$111K 0.89% 32
2015
Q3 		$1.91M Buy
+39,714
New +$2.07M 0.94% 32

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cutter & Co Brokerage's GSK Position: Q2 2016 in Review

Cutter & Co Brokerage sold out of GSK (GSK) in Q2 2016, closing a stake of 17,567 shares — an estimated $890K sold.

Cutter & Co Brokerage first reported a position in GSK in Q3 2015 and held it in 3 quarters. The position peaked at $1.91M in Q3 2015. 742 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • Cutter & Co Brokerage reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • Cutter & Co Brokerage sold 17,567 GSK shares in Q2 2016, an estimated $890K.
  • Cutter & Co Brokerage first reported a position in GSK in Q3 2015 and held it in 3 quarters.
  • Cutter & Co Brokerage's GSK position peaked at $1.91M in Q3 2015.
  • 742 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Cutter & Co Brokerage's 13F filing for Q2 2016, filed 3 Aug 2016.